- Home
- IPDN vs NCNA Comparison
IPDN vs NCNA Comparison
Compare IPDN & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPDN
- NCNA
- Stock Information
- Founded
- IPDN 2003
- NCNA 1997
- Country
- IPDN United States
- NCNA United Kingdom
- Employees
- IPDN N/A
- NCNA N/A
- Industry
- IPDN EDP Services
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- IPDN Technology
- NCNA Health Care
- Exchange
- IPDN Nasdaq
- NCNA Nasdaq
- Market Cap
- IPDN 4.3M
- NCNA 4.5M
- IPO Year
- IPDN 2013
- NCNA 2017
- Fundamental
- Price
- IPDN $2.18
- NCNA $0.05
- Analyst Decision
- IPDN
- NCNA Buy
- Analyst Count
- IPDN 0
- NCNA 2
- Target Price
- IPDN N/A
- NCNA $25.00
- AVG Volume (30 Days)
- IPDN 2.9M
- NCNA 209.1M
- Earning Date
- IPDN 08-12-2025
- NCNA 08-14-2025
- Dividend Yield
- IPDN N/A
- NCNA N/A
- EPS Growth
- IPDN N/A
- NCNA N/A
- EPS
- IPDN N/A
- NCNA N/A
- Revenue
- IPDN $6,508,349.00
- NCNA N/A
- Revenue This Year
- IPDN N/A
- NCNA N/A
- Revenue Next Year
- IPDN N/A
- NCNA N/A
- P/E Ratio
- IPDN N/A
- NCNA N/A
- Revenue Growth
- IPDN N/A
- NCNA N/A
- 52 Week Low
- IPDN $0.97
- NCNA $0.03
- 52 Week High
- IPDN $11.20
- NCNA $10.79
- Technical
- Relative Strength Index (RSI)
- IPDN 58.07
- NCNA 38.50
- Support Level
- IPDN $2.10
- NCNA $0.05
- Resistance Level
- IPDN $3.30
- NCNA $0.13
- Average True Range (ATR)
- IPDN 0.45
- NCNA 0.02
- MACD
- IPDN 0.04
- NCNA 0.00
- Stochastic Oscillator
- IPDN 30.56
- NCNA 4.62
About IPDN Professional Diversity Network Inc.
Professional Diversity Network Inc is engaged in providing access to networking, training, educational and employment services to its registered users. It has three operating segments: the Professional Diversity Network (PDN) segment, which includes online professional networking communities with career resources for diverse cultural groups and employers looking to hire members; and the National Association of Professional Women (NAPW) segment, which is a women-only professional networking organization, the RemoteMore segment. The company generates majority of its revenue from PDN Segment.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.